Related Experiment Video
Updated: May 29, 2026
05:28
Standard Membrane Feeding Assay for the Detection of Plasmodium falciparum Infection in Anopheles Mosquito Vectors
Published on: May 12, 2022
Taking the sting out of malaria
1McLaughlin-Rotman Centre for Global Health, University Health Network, University of Toronto, Toronto, Ontario M5G 1L7, Canada.
Immunity
|August 27, 2011
Summary
Malaria severity is determined by the innate immune response. Sharma et al. discovered a novel DNA sensing pathway in Plasmodium infections that may cause immunopathology.
Area of Science:
- Immunology
- Infectious Diseases
- Molecular Biology
Background:
- The innate immune system plays a critical role in determining the severity and outcome of malaria.
- Understanding the molecular mechanisms underlying the immune response to Plasmodium parasites is crucial for developing effective treatments.
Discussion:
- Sharma et al. (2011) identified a unique DNA sensing pathway involved in the host's response to Plasmodium infections.
- This pathway appears to be a significant factor in the development of immunopathology during malaria.
Key Insights:
- A novel DNA sensing pathway has been implicated in Plasmodium-induced immunopathology.
- This finding sheds light on the complex interplay between parasite DNA and the host immune system.
Outlook:
- Further research into this DNA sensing pathway could reveal new therapeutic targets for managing malaria.
- Investigating this pathway may also provide insights into immune responses in other parasitic infections.
Related Concept Videos
01:29Malaria
Malaria pathogenesis in humans reflects a delicate interplay between parasite biology and host response. Clinical illness reflects a host’s immune response to the parasite’s asexual replication cycle, which is often asymptomatic in individuals with partial immunity. From the parasite's perspective, transmission between mosquito and human with minimal host pathology is evolutionarily advantageous. Among the six Plasmodium species infecting humans, P. falciparum and P. vivax dominate in global...
01:21Antiprotozoal Agents
Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...
00:58Symbiosis
Symbiotic relationships are long-term, close interactions between individuals of different species that affect the distribution and abundance of those species. When a relationship is beneficial to both species, this is called mutualism. When the relationship is beneficial to one species but neither beneficial nor harmful to the other species, this is called commensalism. When one organism is harmed to benefit another, the relationship is known as parasitism. These types of relationships often...
01:15Anthelminthic Agents
Anthelmintic drugs differ significantly from antiparasitic therapies targeting protozoa, primarily due to differences in parasite biology. Whereas most protozoal treatments act on proliferating cells, anthelmintics are typically directed against mature, nonproliferative helminths. The therapeutic approach considers the helminth's reliance on neuromuscular coordination, glucose metabolism, and microtubular integrity for survival, reproduction, and localization within the host. Most anthelmintics...